Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Jul 6, 2022; 10(19): 6580-6586
Published online Jul 6, 2022. doi: 10.12998/wjcc.v10.i19.6580
Figure 2
Figure 2 Immunoadsorption, hormone and cyclophosphamide comprehensive treatment plan. Background anticoagulant therapy; Rivaroxaban 20 mg/d. Immunoadsorption has five specific times: September 12, 2019, September 14, 2019, September 16, 2019, October 9, 2019, October 11, 2019; Cyclophosphamide has four specific times: November 20, 2019, December 28, 2019, September 2, 2019, September 3, 2019; Intravenous immunoglobulin has five specific times: September 18, 2019, September 19, 2019, September 20, 2019, October 13, 2019, October 14, 2019. MP: Methylprednisolone; IG: Immunoglobulin; CTX: Cyclophosphamide; IA: immunoadsorption.